PRTA Price / Book | PROTHENA CORPORATION PUBLIC LIMITED COMPANY

PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) Price / Book

2026-09-03: Price/Book Ratio 1.72.
2026-06-30: Price/Book Ratio 1.77.
2026-03-31: Price/Book Ratio 1.65.
2025-12-31: Price/Book Ratio 1.83.

Historical market capitalization divided by filed shareholder equity.

Available history: 2012-12-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	1.72
2026-06-30	1.77
2026-03-31	1.65
2025-12-31	1.83
2025-09-30	1.78
2025-06-30	1.01
2025-03-31	1.52
2024-12-31	1.53
2024-09-30	1.68
2024-06-30	1.91
2024-03-31	2.65
2023-12-31	3.48
2023-09-30	4.19
2023-06-30	6.28
2023-03-31	4.2
2022-12-31	5.05
2022-09-30	7.17
2022-06-30	3.12
2022-03-31	3.9
2021-12-31	4.95
2021-09-30	6.76
2021-06-30	8.01
2021-03-31	4.73
2020-12-31	2.61
2020-09-30	1.9
2020-06-30	1.78
2020-03-31	1.67
2019-12-31	2.31
2019-09-30	1.08
2019-06-30	1.39
2019-03-31	1.55
2018-12-31	1.27
2018-09-30	1.54
2018-06-30	1.63
2018-03-31	3.57
2017-12-31	3.54
2017-09-30	5.58
2017-06-30	4.24
2017-03-31	4.27
2016-12-31	4.68
2016-09-30	5.15
2016-06-30	2.79
2016-03-31	3.03
2015-12-31	5.99
2015-09-30	3.78
2015-06-30	4.18
2015-03-31	3.78
2014-12-31	1.96
2014-09-30	2.01
2014-06-30	2.01
2014-03-31	4.35
2013-12-31	3.35
2013-09-30	3.62
2013-06-30	2,128.51
2013-03-31	1
2012-12-31	1.02

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
DiaMedica Therapeutics Inc. (DMAC)	United States	$0.423B	-10.11
CYPHERPUNK TECHNOLOGIES INC. (CYPH)	United States	$0.438B	-75.63
Atea Pharmaceuticals, Inc. (AVIR)	United States	$0.414B	-2.26
ARS Pharmaceuticals, Inc. (SPRY)	United States	$0.414B	-3.70
Quoin Pharmaceuticals Ltd. (QNRX)		$0.443B	-17.85
RELMADA THERAPEUTICS, INC. (RLMD)	United States	$0.406B	-11.92
Opus Genetics, Inc. (IRD)	United States	$0.406B	-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)		$0.402B	-2.05
GALECTIN THERAPEUTICS INC (GALT)	United States	$0.399B	-11.06
MapLight Therapeutics, Inc. (MPLT)	United States	$0.459B	-7.10